Document Detail


A Small Peptide Modeled after the NRAGE Repeat Domain Inhibits XIAP-TAB1-TAK1 Signaling for NF-κB Activation and Apoptosis in P19 Cells.
MedLine Citation:
PMID:  21789165     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In normal growth and development, apoptosis is necessary to shape the central nervous system and to eliminate excess neurons which are not required for innervation. In some diseases, however, apoptosis can be either overactive as in some neurodegenerative disorders or severely attenuated as in the spread of certain cancers. Bone morphogenetic proteins (BMPs) transmit signals for regulating cell growth, differentiation, and apoptosis. Responding to BMP receptors stimulated from BMP ligands, neurotrophin receptor-mediated MAGE homolog (NRAGE) binds and functions with the XIAP-TAK1-TAB1 complex to activate p38(MAPK) and induces apoptosis in cortical neural progenitors. NRAGE contains a unique repeat domain that is only found in human, mouse, and rat homologs that we theorize is pivotal in its BMP MAPK role. Previously, we showed that deletion of the repeat domain inhibits apoptosis, p38(MAPK) phosphorylation, and caspase-3 cleavage in P19 neural progenitor cells. We also showed that the XIAP-TAB1-TAK1 complex is dependent on NRAGE for IKK-α/β phosphorylation and NF-κB activation. XIAP is a major inhibitor of caspases, the main executioners of apoptosis. Although it has been shown previously that NRAGE binds to the RING domain of XIAP, it has not been determined which NRAGE domain binds to XIAP. Here, we used fluorescence resonance energy transfer (FRET) to determine that there is a strong likelihood of a direct interaction between NRAGE and XIAP occurring at NRAGE's unique repeat domain which we also attribute to be the domain responsible for downstream signaling of NF-κB and activating IKK subunits. From these results, we designed a small peptide modeled after the NRAGE repeat domain which we have determined inhibits NF-κB activation and apoptosis in P19 cells. These intriguing results illustrate that the paradigm of the NRAGE repeat domain may hold promising therapeutic strategies in developing pharmaceutical solutions for combating harmful diseases involving excessive downstream BMP signaling, including apoptosis.
Authors:
Jennifer A Rochira; Nicholas N Matluk; Tamara L Adams; Aldona A Karaczyn; Leif Oxburgh; Samuel T Hess; Joseph M Verdi
Related Documents :
16140185 - Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells...
10772815 - Adenovirus-mediated transfer of caspase-3 with fas ligand induces drastic apoptosis in ...
9256485 - Cytokine suppression of protease activation in wild-type p53-dependent and p53-independ...
18167185 - Histone deacetylase inhibitor trichostatin a induced caspase-independent apoptosis in h...
19075985 - A recombinant humanized anti-ige monoclonal antibody (omalizumab) in the therapy of mod...
8647195 - Interleukin-12 induces interferon-gamma-dependent switching of igg alloantibody subclass.
Publication Detail:
Type:  Journal Article     Date:  2011-07-18
Journal Detail:
Title:  PloS one     Volume:  6     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2011  
Date Detail:
Created Date:  2011-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e20659     Citation Subset:  IM    
Affiliation:
IGERT Functional Genomics Ph.D. Program, University of Maine, Orono, Maine, United States of America.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting the Tolerated Sequences for Proteins and Protein Interfaces Using RosettaBackrub Flexible...
Next Document:  Analysis of rabies in China: transmission dynamics and control.